Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments

Geis et al. investigate the potential application of hemibodies, a pair of complementary antibody fragments that redirect T cells against cancer-defining antigen combinations, such as CD38 and SLAMF7, to target multiple myeloma. Their study provides evidence that hemibodies can be developed for effe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Geis, Boris Nowotny, Marc-Dominic Bohn, Dina Kouhestani, Hermann Einsele, Thomas Bumm, Gernot Stuhler
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/3ee919498c4342e29413bd80927b94df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3ee919498c4342e29413bd80927b94df
record_format dspace
spelling oai:doaj.org-article:3ee919498c4342e29413bd80927b94df2021-12-02T11:56:22ZCombinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments10.1038/s42003-020-01558-02399-3642https://doaj.org/article/3ee919498c4342e29413bd80927b94df2021-01-01T00:00:00Zhttps://doi.org/10.1038/s42003-020-01558-0https://doaj.org/toc/2399-3642Geis et al. investigate the potential application of hemibodies, a pair of complementary antibody fragments that redirect T cells against cancer-defining antigen combinations, such as CD38 and SLAMF7, to target multiple myeloma. Their study provides evidence that hemibodies can be developed for effective immunotherapy against multiple myeloma.Maria GeisBoris NowotnyMarc-Dominic BohnDina KouhestaniHermann EinseleThomas BummGernot StuhlerNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Maria Geis
Boris Nowotny
Marc-Dominic Bohn
Dina Kouhestani
Hermann Einsele
Thomas Bumm
Gernot Stuhler
Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
description Geis et al. investigate the potential application of hemibodies, a pair of complementary antibody fragments that redirect T cells against cancer-defining antigen combinations, such as CD38 and SLAMF7, to target multiple myeloma. Their study provides evidence that hemibodies can be developed for effective immunotherapy against multiple myeloma.
format article
author Maria Geis
Boris Nowotny
Marc-Dominic Bohn
Dina Kouhestani
Hermann Einsele
Thomas Bumm
Gernot Stuhler
author_facet Maria Geis
Boris Nowotny
Marc-Dominic Bohn
Dina Kouhestani
Hermann Einsele
Thomas Bumm
Gernot Stuhler
author_sort Maria Geis
title Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
title_short Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
title_full Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
title_fullStr Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
title_full_unstemmed Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
title_sort combinatorial targeting of multiple myeloma by complementing t cell engaging antibody fragments
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3ee919498c4342e29413bd80927b94df
work_keys_str_mv AT mariageis combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
AT borisnowotny combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
AT marcdominicbohn combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
AT dinakouhestani combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
AT hermanneinsele combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
AT thomasbumm combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
AT gernotstuhler combinatorialtargetingofmultiplemyelomabycomplementingtcellengagingantibodyfragments
_version_ 1718394801297031168